A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ASC30 Injection in Participants With Obesity

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This is a phase 1 randomized, double-blind, placebo-controlled single ascending dose (SAD) study designed to evaluate the safety and tolerability of ASC 30 injection, for subcutaneous use in participants with obesity.
Epistemonikos ID: 9d4b0d81e69bff928df546242a8e47f873a5e9b6
First added on: Dec 01, 2024